@article{article_877251, title={Treatment approaches in ovarian masses in children}, journal={Pediatric Practice and Research}, volume={9}, pages={73–77}, year={2021}, DOI={10.21765/pprjournal.877251}, url={https://izlik.org/JA76LF63ZU}, author={Ertan, Kübra and Sarıkaya, Mehmet and Akbaş, Hilal and Özcan Sıkı, Fatma and Kara, Buket}, keywords={children, ovary, mass}, abstract={Aim: The aim of this retrospective study is to evaluate clinical features, treatment approaches and outcomes of children with ovarian mass. Materials and Methods: In our clinic, the oncologic charts of children with a mass in the ovary between 2009 and 2020 were analyzed retrospectively. The patients’ demographic features, symptoms and signs, diagnosis, treatments and outcomes were noticed. Results: The age of 55 patients included in the study ranged from two months to 18 years (median, 12.9 years). While the ages of 38 patients were ≥ 10 years (69.1%), 17 of them were <10 years (30.9%). Fifty of the patients underwent elective surgery (91%), four had emergency surgery (7.3%), one patient’s family refused the treatment (1.8%). Of the surgeries performed, 28 were salpingo-oophorectomy (51.9%), 23 were oophorectomy (42.6%), and 3 were cystectomy (5.6%). The types of ovarian mass were germ cell tumors (n: 44, 80%), epithelial tumors (n: 4, 7.3%), stromal tumors (n: 3, 5.5%), simple cyst (n: 2, 3.6%), and others (n: 2, 3.6%). Two patients with malignant tumor (one dysgerminoma patient with ataxia telangiectasia, and the other with yolk sac tumor) died while the others were alive. Conclusion: In children, benign tumors are more prominent and surgical treatment is sufficient. In malignant tumors, overall survival rates have increased with multidisciplinary approaches.}, number={2}, organization={None}